Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (41-50 of 321) with videos related to

Pageof 33
Sort By:
Cancers|March 11, 2023
Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of ProgressDanielle K DePalo, Jonathan S Zager
Annals of Surgical Oncology|January 21, 2022
ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?Steven Morrison, Jonathan S Zager, John Vetto
Oncotargets and Therapy|December 28, 2018
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapyJames Sun, Jonathan S Zager, Zeynep Eroglu
Chinese Clinical Oncology|March 14, 2017
Improving clinical outcomes with pembrolizumab in patients with advanced melanomaDae Won Kim, Jonathan S Zager, Zeynep Eroglu
Expert Opinion on Biological Therapy|September 8, 2016
Intralesional and systemic immunotherapy for metastatic melanomaCarrie Luu, Nikhil I Khushalani, Jonathan S Zager
Expert Opinion on Investigational Drugs|January 8, 2022
The treatment of advanced melanoma: a review of systemic and local therapies in combination with immune checkpoint inhibitors in phase 1 and 2 clinical trialsDanielle K DePalo, Ahmad Tarhini, Jonathan S Zager
Annals of Surgical Oncology|December 15, 2022
Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?Jonathan S Zager, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 MelanomasGiorgos Karakousis, Vernon K Sondak, Jonathan S Zager
Journal of Surgical Oncology|March 13, 2020
Isolated limb infusion: Institutional protocol and implementationMichael J Carr, James Sun, Jonathan S Zager
Expert Opinion on Pharmacotherapy|November 9, 2014
Intralesional therapy for metastatic melanomaSarah Sloot, Omar M Rashid, Jonathan S Zager
Pageof 33

Showing results (41-50 of 321) with videos related to

Sort By:
Pageof 33
Cancers|March 11, 2023
Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of ProgressDanielle K DePalo, Jonathan S Zager
Annals of Surgical Oncology|January 21, 2022
ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?Steven Morrison, Jonathan S Zager, John Vetto
Oncotargets and Therapy|December 28, 2018
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapyJames Sun, Jonathan S Zager, Zeynep Eroglu
Chinese Clinical Oncology|March 14, 2017
Improving clinical outcomes with pembrolizumab in patients with advanced melanomaDae Won Kim, Jonathan S Zager, Zeynep Eroglu
Expert Opinion on Biological Therapy|September 8, 2016
Intralesional and systemic immunotherapy for metastatic melanomaCarrie Luu, Nikhil I Khushalani, Jonathan S Zager
Expert Opinion on Investigational Drugs|January 8, 2022
The treatment of advanced melanoma: a review of systemic and local therapies in combination with immune checkpoint inhibitors in phase 1 and 2 clinical trialsDanielle K DePalo, Ahmad Tarhini, Jonathan S Zager
Annals of Surgical Oncology|December 15, 2022
Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?Jonathan S Zager, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 MelanomasGiorgos Karakousis, Vernon K Sondak, Jonathan S Zager
Journal of Surgical Oncology|March 13, 2020
Isolated limb infusion: Institutional protocol and implementationMichael J Carr, James Sun, Jonathan S Zager
Expert Opinion on Pharmacotherapy|November 9, 2014
Intralesional therapy for metastatic melanomaSarah Sloot, Omar M Rashid, Jonathan S Zager
Pageof 33